KM Research Hub
← 返回论文库
待处理 入排:排除 图源:待检查

ETOP 25-23 ADOPT-lung: An international, multicentre, open-label randomised phase III trial to evaluate the benefit of adding adjuvant durvalumab after neoadjuvant chemotherapy plus durvalumab in patients with stage IIB-IIIB (N2) resectable NSCLC.

Sabine Schmid, Georgia Dimopoulou, Paul van Schil, David König, Laetitia Mauti, Malinda Itchins, Martin Früh, Kersti Oselin, Lorenza Landi, Maurice Pérol, Sanjay Popat, Clemens Aigner, Patrick Forde, Wouter K de Jong, Heidi Roschitzki-Voser, Eva Grolimund, Barbara Ruepp, Benjamin Solomon, Stephen Finn, Urania Dafni, Rolf Stahel, Solange Peters, ETOP 25-23 ADOPT-lung collaborators

Lung Cancer 206 108635

PMID40582281
PMCID-
DOI10.1016/j.lungcan.2025.108635
发表日期2025-06-29
摘要

摘要

无摘要

KM 提取结果

0 个 Figure · 0 个 KM 面板

尚未提取到 KM 面板。